Flow cytometric study of low density lipoprotein receptors: Biological and clinical interest;Étude du récepteur des lipoprotéines de basse densité par cytométrie en flux: Intérêts biologiques et cliniques

Annales de Biologie Clinique

Volumn 62, Issue 1, 2004, Pages 87-91

  Duvillard, L ^a   Gambert, P ^a   Lizard, G ^a  

^a HÔPITAL DU BOCAGE   (France)

Author keywords

Calibration bead; Flow cytometry; LDL receptor

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR;

ARTICLE; FLOW CYTOMETRY; HUMAN; METHODOLOGY;

FLOW CYTOMETRY; HUMANS; RECEPTORS, LDL;

EID: 1242265577     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Hussain MM, Strickland DK, Bakillah A. The mammalian low-density receptor family. Annu Rev Nutr 1999 ; 19 : 141-72.
2. Marsot S. Hypercholestérolémies primaires. Encyclopédie Médico Chirurgicale 2000 ; 10-368-B10 : 1-7.
3. Horton JD, Goldstein JL, Brown MS. SREBPs : activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002 ; 109 : 1125-31.
4. Duvillard L, Florentin E, Lizard G, et al. Cell surface expression of low density lipoprotein receptor is decreased in type 2 diabetic patients and is normalized by insulin therapy. Diabetes Care (sous presse).
5. Streicher R, Kotzka J, Muller-Wieland D, Munck M, Avci H, Krone W. SREBP-1 mediates activation of the low density lipoprotein receptor promoter by insulin and insulin-like growth factor-I. J Biol Chem 1996 ; 271 : 7128-33.
6. Bakker O, Hudig F, Meijssen S, Wiersinga WM. Effects of triiodothyronine and amiodarone on the promoter of the human LDL receptor gene. Biochem Biophys Res Commun 1998 ; 249 : 517-21.
7. Abbey M, Owen A, Suzakawa M, Roach P, Nestel PJ. Effects of menopause and hormone replacement therapy on plasma lipids, lipoproteins and LDL-receptor activity. Maturitas 1999 ; 33 : 259-69.
8. Parini P, Angelin B, Lobie PE, Norstedt G, Rudling M. Growth hormone specifically stimulates the expression of low density lipoprotein receptors in human hepatoma cells. Endocrinology 1995 ; 136 : 3767-73.
9. Al Rayyes O, Wallmark A, Floren CH. Additive inhibitory effect of hydrocortisone and cyclosporine on low density lipoprotein receptor activity in cultured HepG2 cells. Hepatology 1997 ; 26 : 967-71.
10. Ruan XZ, Varghese Z, Fernando R, Moorhead JF. Cytokine regulation of low-density lipoprotein receptor gene transcription in human mesangial cells. Nephrol Dial Transplant 1998 ; 13 : 1391-7.
11. Schmilz G, Brüning T, Kovacs E, Barlage S. Fluorescence flow cytometry of human leucocytes in the detection of LDL receptor defects in the differential diagnosis of hypercholesterolemia. Arterioscl Thromb 1993 ; 13 : 1053-65.
12. Powel EE, Kroon PA. Low density lipoprotein receptor and 3-hydroxy-3-methyl coenzyme A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver. J Clin Invest 1994 ; 93 : 2168-74.
13. Urdal P, Leren TP, Tonstad S, Lund PK, Ose L. Flow cytometric measurement of low density lipoprotein receptor activity validated by DNA analysis in diagnosing heterozygous familial hypercholesterolemia. Cytometry 1997 ; 30 : 264-8.
14. Beisiegel U, Schneider WJ, Goldstein JL, Anderson RGW, Brown MS. Monoclonal antibodies to the low density lipoprotein receptor as probes for study of receptor-mediated endocytosis and the genetics of familial hypercholesterolemia. J Biol Chem 1981 ; 256 : 11923-31.
15. 2+ and monoclonal antibodies, but not lipoproteins. J Biol Chem 1987 ; 262 : 17443-9.
16. Wedemeyer N, Pötter T, Wetzlich S, Göhde W. Flow cytometry quantification of competitive reverse transcription-PCR products. Clin Chem 2002 ; 48 : 1398-405.